JTC (JTC) shares tick up 4.59% to 775p following positive trading update for 2021

On Thursday, the global professional services business said new business performance for the year ended 31 December 2021 was strong despite the continuing effects of COVID-19. 

The annualised value of new business won increased by around 16% on a year-on-year basis to £20.9m, up from £17.9m in 2020 with the wins including the largest single new business mandate ever secured by JTC, an outsourcing mandate from a blue-chip global bank.

The Company informed investors that it maintains its medium-term guidance metrics of 8%-10% net organic revenue growth; underlying EBITDA margin of 33%-38%; net debt of 1.5x to 2.0x underlying EBITDA as well as cash conversion in the range 85%-90%.

Origo Partners (OPP) shares jump 50% to 0.215p as it returns $1.7m to shareholders

On Wednesday, the closed-end investment company announced that it will return around $1.7 million to shareholders and that it had also agreed to sell its interest in Moly World for $0.2m.

Origo outlined that it will sell its entire interest in Moly World to Moly World’s controlling shareholder for $0.2m, with an initial payment of $0.1m having already been received.  The remaining $100,000, due on completion, is expected to be received by 31 March 2022.

Creo Medical Group (CREO) shares jump 12.01% to 172.5p as revenue beats expectations 

On Thursday, the medical device firm, which is focused on surgical endoscopy, said it expects to report revenue for the year to 31 December 2021, ahead of expectations, just over £25m.

Creo said it has continued to build momentum through sustained commercial progress during 2021 despite COVID-19 related challenges, as group revenue from its core product portfolio continues to grow in-line with cumulative revenue forecasts

set out back in December 2016.

As at 31 December 2021, the Company had a net cash position of approximately £44 million.

“With our strong cash position and clear strategy, Creo Medical Group is well positioned to deliver shareholder value in 2022,” the group’s CEO, Craig Gulliford, told investors yesterday.

I3 Energy (I3E) shares rose 9.94% to 17p after it declares monthly dividend

On Thursday, the independent oil and gas company with assets and operations in the UK and Canada, said it would move from a bi-annual to a monthly schedule for its dividend payments.

It will declare its first monthly dividend during the first half of February for payment in March.

I3 has forecasted robust cash flow generation from production following an intense period of accretive growth since its mid-2020 entry into the Western Canadian Sedimentary Basin. It said ‘predictable, low-decline assets’ continue to outperform management’s expectations.

As previously announced, during the course of 2022 i3 Energy will pay a minimum dividend totalling £11.827 million, representing a 7.1% yield at the closing price on 2 February 2022.